MarketInOut Stock Screener Log In | Sign Up

Bioventix Plc

LSE • Healthcare • Biotechnology • Quote as of 10/27/2026 16:35
Bioventix Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization105.07 mln
Float4.44 mln
Earnings Date10/26/2026

EPS

143
Exceptional

P / E

13.84
Fair value

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.16
Caution advised

Relative Strength

99 / 100
Top performer

Pre-Tax Margin

77%
Exceptional margin

Business Description

Founded in 2003 and headquartered in Farnham, United Kingdom, Bioventix PLC develops and sells specialised sheep-derived antibodies used in medical diagnostic tests around the world. The company's products support testing across a wide range of health areas, including thyroid function, vitamin D levels, heart conditions, fertility, cancer, and drug use. Bioventix also offers testing solutions for measuring human exposure to industrial pollutants, including options that can be used outside of a laboratory setting. In addition, the company provides custom antibody development services and tools designed to speed up environmental and industrial health monitoring.

Key Fundamentals

EPS143
P/E13.84
ROE65.87
RPS2.48
ROIC120
ROA57.34
EBITDA, mln9.68
EV / EBITDA10.39
EV / EBIT10.46
Revenue, mln12.54
EV / Revenue8.02

Quote Details

Last 1,990.00
Change 15 (0.76%)
Open 1,955.00
Volume 14,688
Turnover 29,229,120
Average Volume 17,167

Financial Ratios

Pre-Tax Profit Margin77
Leverage Ratio1.18
Current Ratio6.12
Price / Book9.47
Price / Tangible Book9.48
Price / Cash Flow13.20
Price / Free Cash Flow13.35
Price / Sales8.44
PEG Ratio2.96

Financial Strength

Altman Z-Score53.38
Piotroski F-Score 5 / 9
Beneish M-Score-2.16
Price to Intrinsic Value1.20
Price to Graham Number2.45
Shiller PE Ratio13.52

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.19% 92 / 100   
1 Month 20.61% 98 / 100   
2 Months 31.69% 96 / 100   
6 Months 18.81% 87 / 100   
1 Year 16.85% 70 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog